JUN 05, 2019 12:00 PM PDT

Use of Functional Inhibitors of Acid Sphingomyelinase (FIASMA) to Treat Intracelluar Bacterial Infections

WRITTEN BY: Dena Aruta

Researchers at Virginia Commonwealth University presented the findings of their study published in Life Science Alliance that certain antidepressants may have the potential to treat infections with intracellular microorganisms. These drugs, known as functional inhibitors of acid sphingomyelinase (FIASMAs), interfere with acid sphingomyelinase (ASM), an enzyme that aids in the release of LDL cholesterol from the lysosome. The activity of ASM is an integral part of the infectious process with intracellular microorganisms because they target cholesterol within the cells. The FIASMAs analyzed in this study were desipramine, amitriptyline, and nortriptyline, which belong to the drug class, tricyclic antidepressants.

"Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases," Carlyon said.

Anaplasma phagocytophilum, Coxiella burnetii, Chlamydia trachomatis, and Chlamydia pneumoniae were used to demonstrate that the activity of ASM is a vital part of the infectious process. The four organisms are "obligate intracellular vacuole-adapted bacterial pathogens that target host cholesterol trafficking pathways" and are responsible for the diseases human granulocytic anaplasmosis, Q fever, pneumonia, and a sexually transmitted infection. 

The findings of the study demonstrated that ASM inhibition was more effective with desipramine when testing  A.phagocytophilum and C. burnetii than the other two organisms. Desipramine was less effective with C. pneumoniae since it uses sources of both LDL cholesterol and non-LDL cholesterol during its growth cycle. C. trachomatis showed even less inhibition than C. pneumoniae. 

"It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated," Carlyon said. "These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetii."

Carlyon went on to state that: "What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria," Carlyon said. "I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body."

The researchers suggest that, since these drugs are likely to prevent resistance, they should be evaluated clinically as an alternative to antibiotics or in conjunction with one to augment their efficacy. 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
JUN 18, 2019
Health & Medicine
JUN 18, 2019
Glue, It's What Keeps A Heart Together
If you’ve ever had a cavity filled at the dentist, you know the steps. First goes in the filling, followed by a wand of UV light to harden the materi...
JUN 18, 2019
Cancer
JUN 18, 2019
Uterine Cancer Rises, Especially Among Black Women
A recent study from the National Cancer Institute (NCI) found uterine cancer rates among all women rose about 1 percent per year between 2003 and 2015. It&...
JUN 18, 2019
Cell & Molecular Biology
JUN 18, 2019
Scientists Discover Why Arteries Harden & Find a Potential Treatment
As we get older, our arteries slowly begin to stiffen and then harden, which can lead to many serious complications. Now there may be a way to treat it....
JUN 18, 2019
Health & Medicine
JUN 18, 2019
Cannabis Use Dating Back to 500 B.C.
Deep in the Pamir Mountains in western China, it appears that ancient communities, dating back as far as 500 B.C., may have used cannabis in mortuary ritua...
JUN 18, 2019
Cancer
JUN 18, 2019
Proton Therapy May Reduce Second Cancer Risk More Than Other Radiation Types
A new study finds that proton beam radiation therapy (PBRT) might lead to a reduction in the risk for a second cancer, when compared to other types of cont...
JUN 18, 2019
Health & Medicine
JUN 18, 2019
Remember Joe Camel? E-cigarette cartoon ads increase the chances of vaping
Do you remember the infamous "Joe Camel" advertisements for cigarettes back in the 1980s and 90s? These ads successfully got a generation of youn...
Loading Comments...